Mutares Puts Magirus on the Block as Dividend Payout and US Ambitions Take Centre Stage

Mutares posts €130.4M net income, eyes Magirus exit, buys back bonds, and expands into US and specialty chemicals amid share price lows.

Mutares has unveiled its audited 2025 annual report, and the numbers tell a story of a company in transition. The Munich-based private equity firm is juggling a record exit pipeline, a fresh push into specialty chemicals, and a delicate balance sheet repair — all while its share price languishes near recent lows.

The holding company’s net income climbed to €130.4 million in 2025, up from €108.3 million a year earlier, driven largely by a surge in portfolio company disposals. Group revenue hit €6.5 billion, while EBITDA multiplied to roughly €675 million, propelled by the full exit from Steyr Motors and other successful divestitures. Revenue from advisory and management fees came in at €106.2 million.

Shareholders are set to benefit from the windfall. The board has proposed a minimum dividend of €2.00 per share for 2025, to be voted on at the annual general meeting scheduled for 3 July. Should additional bumper disposal proceeds materialise, management has flagged the possibility of a further performance-linked payout.

Magirus Takes Centre Stage

All eyes are on Magirus, the firefighting and defence equipment subsidiary that has become the centrepiece of Mutares’s value realisation strategy. The order book at Magirus has swelled to well over €800 million — a record level that provides full visibility for 2026 and covers large portions of 2027. The defence business, in particular, is expanding rapidly and generating attractive margins.

Mutares is now actively exploring options for the asset, weighing an initial public offering against a direct sale. No decision has been reached, but the outcome is expected to be a defining moment for the group’s valuation.

Debt Fix and Dilution Bite

The strong operational performance has been overshadowed by balance sheet strain. Mutares breached a covenant on its 2023/2027 bond after net debt relative to equity crossed the agreed threshold. Creditors granted a waiver, buying the company time, but the underlying issue remains unresolved.

To address the problem permanently, Mutares will begin buying back its own bonds from the second quarter onwards, targeting at least €25 million in repurchases per quarter. The move is designed to reduce leverage and restore creditor confidence.

The capital increase completed in April 2026 raised €105 million gross, providing the financial firepower for expansion. But it came at a cost. The 4.2 million new shares that began trading have diluted existing holdings and shifted the power structure within the company. The Laik family’s voting stake has fallen below the 25% threshold, removing the blocking minority they previously held on key decisions.

US Expansion and New Segment

The fresh capital is earmarked for a bold transatlantic push. Mutares has identified roughly 15 acquisition targets in the United States, with a combined revenue pipeline of €4.8 billion. The company is also building a new segment, Chemicals & Materials, which will take it into specialty chemicals and high-performance materials for the first time, with a focus on North and South America.

The exit machine is running at full throttle. Kalzip, WIJ Special Media, and the inTime Group have already been sold. Relobus and Conexus are under signed agreements and awaiting completion. One further portfolio company is in the final transaction phase, with proceeds that could reach triple-digit millions.

Guidance and Market Reaction

For 2026, Mutares is sticking to its forecast. Group revenue is expected to land between €7.9 billion and €9.1 billion, while the holding company’s net profit is targeted at €165 million to €200 million. The first quarter of 2026 has been described as “extremely robust” by management.

The market, however, remains unconvinced. The stock traded at around €24.85 on Tuesday, down nearly 2% on the day and roughly 16% below its level at the start of the year. It sits well below its 200-day moving average of €29.25, reflecting persistent investor concerns over dilution, debt, and the pace of value realisation.

The first-quarter report is due in May, followed by the annual general meeting on 3 July, where the dividend proposal and the strategic direction will be put to a vote. For a company that has delivered record profits and is sitting on a pipeline of exits, the disconnect between operational performance and share price is becoming increasingly hard to ignore.